Cargando…
Hereditary Risk Evaluation for Borderline Ovarian Tumors Based on Immunohistochemistry
OBJECTIVES: Borderline ovarian tumors (BOT) are premalignant lesions. Approximately 10% of all epithelial ovarian cancers are known to be hereditary with hereditary breast and ovarian cancer (HBOC) accounting for approximately 90% of cases; the remaining 10% are attributable to Lynch syndrome, also...
Autores principales: | Park, Jung Min, Kim, Min Kyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Menopause
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4217565/ https://www.ncbi.nlm.nih.gov/pubmed/25371887 http://dx.doi.org/10.6118/jmm.2014.20.1.14 |
Ejemplares similares
-
Controversies in borderline ovarian tumors
por: Seong, Seok Ju, et al.
Publicado: (2015) -
Clinicopathological aspects of patients with recurrence of borderline ovarian tumors
por: Oh, Sumin, et al.
Publicado: (2015) -
One Case of a BRCA1 Germ Line Mutation Ovarian Carcinoma Patient Based on Abnormal Immunohistochemistry Finding
por: Kim, Hyun Joo, et al.
Publicado: (2014) -
Computed Tomography Indicators for Differentiating Stage 1 Borderline Ovarian Tumors from Stage I Malignant Epithelial Ovarian Tumors
por: Moon, Min Hoan, et al.
Publicado: (2023) -
Oncologic and obstetric outcomes of conservative surgery for borderline ovarian tumors in women of reproductive age
por: Lee, Se Yun, et al.
Publicado: (2017)